陈静, 何霞云. Advance in current management of patients with anaplastic thyroid carcinoma[J]. China Oncology, 2014, 24(4): 310-315. DOI: 10.3969/j.issn.1007-3969.2014.04.012.
Anaplastic thyroid cancer (ATC) is the most aggressive thyroid tumor
with lower morbidity and higher mortality rates. Radical surgery could improve local control and survival rates. Conformal radiotherapy is superior to conventional radiotherapy
which could improve the patients’ quality of life. There are a few chemotherapeutic drugs against ATC
and the outcome of chemotherapy alone is modest. Concurrent chemoradiotherapy can prolong the survival. Targeted therapy brings new hope for refractory patients. Many cancer centers are exploring surgery
radiotherapy
chemotherapy
targeted therapy and other biological treatment of comprehensive application
in order to enhance the curative effect. This article reviewed the foregoing treatments for ATC.